Clinical and Biotechnology Business Unit, Shimadzu Corporation, Kyoto, Japan.
Proteomics. 2010 May;10(9):1780-93. doi: 10.1002/pmic.200900783.
To establish a strategy for the comprehensive identification of human N-myristoylated proteins, the susceptibility of human cDNA clones to protein N-myristoylation was evaluated by metabolic labeling and MS analyses of proteins expressed in an insect cell-free protein synthesis system. One-hundred-and-forty-one cDNA clones with N-terminal Met-Gly motifs were selected as potential candidates from approximately 2000 Kazusa ORFeome project human cDNA clones, and their susceptibility to protein N-myristoylation was evaluated using fusion proteins, in which the N-terminal ten amino acid residues were fused to an epitope-tagged model protein. As a result, the products of 29 out of 141 cDNA clones were found to be effectively N-myristoylated. The metabolic labeling experiments both in an insect cell-free protein synthesis system and in the transfected COS-1 cells using full-length cDNA revealed that 27 out of 29 proteins were in fact N-myristoylated. Database searches with these 27 cDNA clones revealed that 18 out of 27 proteins are novel N-myristoylated proteins that have not been reported previously to be N-myristoylated, indicating that this strategy is useful for the comprehensive identification of human N-myristoylated proteins from human cDNA resources.
为了建立一种全面鉴定人源 N-豆蔻酰化蛋白的策略,我们通过昆虫细胞无细胞蛋白合成系统中表达的蛋白质的代谢标记和 MS 分析,评估了人 cDNA 克隆对蛋白质 N-豆蔻酰化的易感性。从大约 2000 个 Kazusa ORFeome 项目人 cDNA 克隆中,选择了 141 个具有 N 端 Met-Gly 基序的 cDNA 克隆作为潜在的候选物,并使用融合蛋白评估了它们对蛋白质 N-豆蔻酰化的易感性,其中 N 端的十个氨基酸残基融合到一个表位标记的模型蛋白上。结果,在昆虫细胞无细胞蛋白合成系统和转染的 COS-1 细胞中的代谢标记实验中,发现 141 个 cDNA 克隆中有 29 个产物可有效地进行 N-豆蔻酰化。全长 cDNA 的代谢标记实验表明,29 个蛋白中的 27 个实际上是 N-豆蔻酰化的。用这 27 个 cDNA 克隆进行数据库搜索显示,27 个蛋白中的 18 个是新的 N-豆蔻酰化蛋白,以前没有报道过它们是 N-豆蔻酰化的,这表明该策略可用于从人 cDNA 资源中全面鉴定人源 N-豆蔻酰化蛋白。